Entinostat in Chinese Postmenopausal Women Patients With Locally Recurrent or Metastatic Breast Cancer
Clinical trial NCT02833155 · COMPLETED
Trial details
- NCT number
- NCT02833155
- Sponsor
- Taizhou EOC Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-29
- Primary completion
- 2018-07-18
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.